LS
BXC icon

Livforsakringsbolaget Skandia’s BlueLinx BXC Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio BXC Stock Details BXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,500
Closed -$155K – 584
2022
Q3 		$155K Hold
2,500
– – 0.02% 248
2022
Q2 		$167K Buy
+2,500
New +$188K 0.01% 366

Other funds holding BXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $646M AUM 39.9% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Livforsakringsbolaget Skandia's BXC Position: Q4 2022 in Review

Livforsakringsbolaget Skandia sold out of BlueLinx (BXC) in Q4 2022, closing a stake of 2,500 shares — an estimated $155K sold.

Livforsakringsbolaget Skandia first reported a position in BXC in Q2 2022 and held it in 2 quarters. The position peaked at $167K in Q2 2022. 145 funds tracked by Wall St. Rank hold BXC as of Q4 2022.

  • Livforsakringsbolaget Skandia reported no remaining BlueLinx position as of Q4 2022 after selling out during the quarter.
  • Livforsakringsbolaget Skandia sold 2,500 BlueLinx shares in Q4 2022, an estimated $155K.
  • Livforsakringsbolaget Skandia first reported a position in BlueLinx in Q2 2022 and held it in 2 quarters.
  • Livforsakringsbolaget Skandia's BlueLinx position peaked at $167K in Q2 2022.
  • 145 funds tracked by Wall St. Rank held BlueLinx as of Q4 2022.

Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2022, filed 13 Feb 2023.